My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Alembic Pharma Research Report - 16th Dec 2015

Agrichemical | Published on Aug 10th 2012


Alembics 1QFY2013 results have come below expectations. On the sales front, the company grossed sales of Rs366cr, registering a revenue growth of 6.6% yoy, lower than our expectations of Rs390cr. On the operating front, the company posted an OPM of 14.3% vs an expectation of 15.3%. This, along with lower than expected net sales, lead the net profits to come below expectations at Rs31cr (expectation was of Rs33cr). At the current market price, the stock is trading at an attractive valuation. Hence, we maintain our Buy view on the stock.

Download Full Report


CMP 59
Target Price 91
Investment Period12 Months

Trade Securely


Portfolio Tracking & Trading Application View Demo